These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Panzenböck B, Bartunek P, Mapara MY, Zenke M. Blood; 1998 Nov 15; 92(10):3658-68. PubMed ID: 9808559 [Abstract] [Full Text] [Related]
25. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor. Klingmüller U. Eur J Biochem; 1997 Nov 01; 249(3):637-47. PubMed ID: 9395308 [Abstract] [Full Text] [Related]
26. Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells. Fukumoto T, Kubota Y, Kitanaka A, Yamaoka G, Ohara-Waki F, Imataki O, Ohnishi H, Ishida T, Tanaka T. Cell Signal; 2009 Dec 01; 21(12):1775-83. PubMed ID: 19665053 [Abstract] [Full Text] [Related]
27. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways. Shi J, Yuan B, Hu W, Lodish H. Exp Hematol; 2016 Nov 01; 44(11):1044-1058.e5. PubMed ID: 27473563 [Abstract] [Full Text] [Related]
28. In vivo effects of interleukin-11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis. de Haan G, Dontje B, Engel C, Loeffler M, Nijhof W. Br J Haematol; 1995 Aug 01; 90(4):783-90. PubMed ID: 7545423 [Abstract] [Full Text] [Related]
29. Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts. Barnache S, Mayeux P, Payrastre B, Moreau-Gachelin F. Blood; 2001 Oct 15; 98(8):2372-81. PubMed ID: 11588033 [Abstract] [Full Text] [Related]
30. Biological significance of MAPK, AKT and JAK-STAT protein activation by various erythropoietic factors in normal human early erythroid cells. Ratajczak J, Majka M, Kijowski J, Baj M, Pan ZK, Marquez LA, Janowska-Wieczorek A, Ratajczak MZ. Br J Haematol; 2001 Oct 15; 115(1):195-204. PubMed ID: 11722433 [Abstract] [Full Text] [Related]
34. Stem cell factor prevents Fas-mediated apoptosis of human erythroid precursor cells with Src-family kinase dependency. Nishio M, Oda A, Koizumi K, Satoh I, Sato Y, Endoh T, Tsutsumi A, Fujihara M, Ikebuchi K, Ikeda H, Koike T, Sawada KI. Exp Hematol; 2001 Jan 15; 29(1):19-29. PubMed ID: 11164102 [Abstract] [Full Text] [Related]
35. Btk is required for an efficient response to erythropoietin and for SCF-controlled protection against TRAIL in erythroid progenitors. Schmidt U, van den Akker E, Parren-van Amelsvoort M, Litos G, de Bruijn M, Gutiérrez L, Hendriks RW, Ellmeier W, Löwenberg B, Beug H, von Lindern M. J Exp Med; 2004 Mar 15; 199(6):785-95. PubMed ID: 15007095 [Abstract] [Full Text] [Related]
36. Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling. Mori M, Uchida M, Watanabe T, Kirito K, Hatake K, Ozawa K, Komatsu N. J Cell Physiol; 2003 May 15; 195(2):290-7. PubMed ID: 12652655 [Abstract] [Full Text] [Related]
39. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Badache A, Hynes NE. Cancer Res; 2001 Jan 01; 61(1):383-91. PubMed ID: 11196191 [Abstract] [Full Text] [Related]
40. The signaling pathways of erythropoietin and interferon-gamma differ in preventing the apoptosis of mature erythroid progenitor cells. Paiboonsukwong K, Choi I, Matsushima T, Abe Y, Nishimura J, Winichagoon P, Fucharoen S, Nawata H, Muta K. Int J Hematol; 2003 Dec 01; 78(5):421-8. PubMed ID: 14704034 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]